Antimicrobial resistance: The European animal health industry calls for science-based policies focusing on responsible use
Brussels, 23 October 2015 - IFAH-Europe has called for policies regarding the use of antibiotics in animals to be based soundly on science and for the focus to be on Responsible Use of antibiotics.
Brussels, 23 October 2015 - During the conference – "Farmers and veterinarians together to tackle antimicrobial resistance" - held today under the Luxembourg Presidency of the Council of the European Union, the International Federation for Animal Health - Europe (IFAH-Europe) called for policies regarding the use of antibiotics in animals to be based soundly on science and for the focus to be on Responsible Use of antibiotics.
"The animal health industry is strongly committed to both public and animal health and we need to be innovative in order to combat disease challenges. The current reform of the regulation on veterinary medicines is a great opportunity to promote innovation in animal health. We call for a predictable, science-based environment that encourages companies to invest both in improving existing antibiotics as well as researching innovative alternatives," said IFAH-Europe Chairman, Christian Behm.
The animal health industry in Europe advocates that policies on tackling antimicrobial resistance (AMR) should focus on promoting Responsible Use through platforms such as EPRUMA1 and monitoring of use of antibiotics in veterinary medicine through programmes such as ESVAC2, as well as monitoring the development of resistance. The main objective should be to reduce resistance to antibiotics, not simply to reduce antibiotic use. Care should be taken to ensure that any restrictions on the use of antibiotics in veterinary medicine do not adversely impact animal health and welfare.
Measures need to be put in place to ensure that each and every use of antibiotics in both human and veterinary medicine is responsible. This is vital to ensure their continued use in the future and to safeguard the health and welfare of animals and people alike.
This content is published by the Parliament Magazine on behalf of our partners.
The EU's new clinical trials regulation still has a few implementation challenges to overcome, says Prof. Christian Dittrich.
Antibiotic resistance poses a serious risk. Roxanne Feller of IFAH-Europe explains how the animal health industry’s considered and responsible approach plays a vital role in containing the threat...
Early intervention is a cost-effective solution to reducing the burden of musculoskeletal disorders, writes Juan Jover.